In addition, synergistic cytotoxic activity is observed during the simultaneous inhibition of histone deacetylase (HDAC) and menin–MLL in the interaction process, especially for AML cells that carry MLL rearrangements. The gene discussed is MEN1; the disease is acute myeloid leukemia.